发明名称 |
GENE EDITING FOR HIV GENE THERAPY |
摘要 |
The present disclosure is in the field of genome engineering, particularly targeted integration of anti-HIV transgenes into the genome of a cell for the treatment and/or prevention of HIV. |
申请公布号 |
US2016022737(A1) |
申请公布日期 |
2016.01.28 |
申请号 |
US201514807595 |
申请日期 |
2015.07.23 |
申请人 |
Sangamo BioSciences, Inc. ;University of Southern California |
发明人 |
Gregory Philip D.;Wang Jianbin;Cannon Paula M. |
分类号 |
A61K35/28;C12N15/85 |
主分类号 |
A61K35/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of generating a cell that will not sustain HIV infection, the method comprising genetically modifying the cell such that:
(i) an endogenous restriction factor is modified to increase its activity against HIV; (ii) an endogenous viral host factor gene is modified to decrease its ability to support HIV infection; or (iii) an exogenous transgene encoding a Trim5α-Cyp fusion protein is inserted into an endogenous safe harbor locus wherein the cell will not sustain HIV infection. |
地址 |
Richmond CA US |